Tavaborole

Pharm Company: * TARO PHARMA USA INC
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tavaborole Overview

Tavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole was approved by the US FDA in July 2014.[1] The medication inhibits an essential fungal enzyme, leucyl-tRNA synthetase, that is required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and then cell death, eliminating the fungal infection. Contents 1 Medical...

Read more Tavaborole Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tavaborole

Recent Tavaborole Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tavaborole
  • Solution: 5%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tavaborole: (6 results)

Sorted by National Drug Code
  • 0574-0157 Tavaborole 43.5 mg/ml Topical Solution by Paddock Laboratories, LLC.
  • 21922-020 Tavaborole 43.5 mg/ml Topical Solution by Encube Ethicals Private Limited
  • 51862-690 Tavaborole 43.5 mg/ml Topical Solution by Mayne Pharma Inc.
  • 62332-467 Tavaborole 43.5 mg/ml Topical Solution by Alembic Pharmaceuticals, Inc.
  • 69097-686 Tavaborole 43.5 mg/ml Topical Solution by Cipla USA Inc.
  • 69238-1657 Tavaborole 43.5 mg/ml Topical Solution by Amneal Pharmaceuticals Ny LLC

Other drugs which contain Tavaborole or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA